|
|
 | | | |
- close
- close
- close
- close
FierceBiotech
Jan 17
Comment
Astex Pharmaceuticals ($ASTX) says it has decided to hand over the epigenetics program SuperGen was partnered on with GlaxoSmithKline ($GSK) following its merger with the biotech company. SuperGen partnered with GSK back in 2009, but the program...
StreetInsider.com
Sep 12
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/SuperGen+%28ASTX%29+Officially+Changes+Name+to+Astex+Pharmaceuticals%2C+Ticker+to+%27ASTX%27/6776652.html for the full story.
StreetInsider.com
Sep 2
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/SuperGen+%28SUPG%29%28ASTX%29+to+Change+Name+to+Astex+Pharmaceuticals%2C+Ticker+to+%27ASTX%27/6759649.html for the full story.
StreetInsider.com
Aug 3
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/SuperGen%2C+Inc.+%28SUPG%29+Tops+Q2+EPS+by+1c/6680282.html for the full story.
StreetInsider.com
Jul 13
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/SuperGen+%28SUPG%29+Notes+FDA+Acceptance+of+DACOGEN+NDA+for+Review/6635092.html for the full story.
StreetInsider.com
Jun 28
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/SuperGen%27s+%28SUPG%29+CEO+Elected+to+Biotechnology+Industry+Organization+Board/6607145.html for the full story.
MarketWatch
Apr 7
Comment
Shares of SuperGen Inc. fell 12% to $2.84 in afternoon trading Thursday, the day after it announced it was merging with Astex Therapeutics Ltd., a privately-held biotech company based in the U.K. The combined company, to be called Astex...
FierceBiotech
Apr 7
Comment
Dublin, CA-based SuperGen has struck a deal to acquire the UK biotech Astex--a 2006 Fierce 15 winner--absorbing its promising drug discovery engine and a string of partnerships that now tie the U.S. biotech to some of the world's largest drug...
TheStreet.com
Mar 4
Comment
NEW YORK (TheStreet) -TheStreet Ratings' stock model upgraded SuperGen Inc to 'Buy' from 'Hold'. Net income at this $173 million market cap, pharmaceutical company grew to $6.8 million, a 189% increase over the prior fourth quarter....
MarketWatch
Oct 26
Comment
Biotech group raises its 2010 financial forecast, and Ariad slides on the pricing of a stock offering.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_2/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
